MYNZ
Mainz Biomed BV
NASDAQ: MYNZ · HEALTHCARE · DIAGNOSTICS & RESEARCH
$0.41
-3.73% today
Updated 2026-05-01
Market cap
$7.90M
P/E ratio
—
P/S ratio
16.01x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
Mainz Biomed BV (MYNZ) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $715959.00 | $673270.00 | $10.04M | $20.24M | $15.41M | $13.24M |
| Cash & equivalents | $203588.00 | $122568.00 | $8.73M | $17.14M | $7.07M | $6.24M |
| Current assets | $260006.00 | $186398.00 | $9.61M | $18.38M | $8.98M | $7.84M |
| Total liabilities | $2.67M | $3.41M | $3.68M | $6.14M | $12.16M | $7.19M |
| Current liabilities | $459714.00 | $701954.00 | $1.35M | $4.24M | $9.24M | $5.95M |
| Long-term debt | $369477.00 | $447181.00 | $1.94M | $943214.00 | $1.03M | — |
| Shareholder equity | $-1.95M | $-2.74M | $6.36M | $14.10M | $3.25M | $6.05M |
| Retained earnings | $-4.37M | $-4.95M | $-16.64M | $-43.03M | $-69.33M | $-90.98M |
| Accounts receivable | $40800.00 | $44241.00 | $17757.00 | $259138.00 | $354510.00 | $213745.00 |
| Inventory | — | — | $-863.14M | $175469.00 | $613638.00 | $372870.00 |
| Goodwill | — | — | — | — | — | — |